CIK 0001727196 · Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823750435
- Phone
- 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-10 | Myles Edward H COO & CFO | Option exercise 10b5-1 | +5,313 | $10.00 | $53K | 235,780 |
| 2025-03-10 | Myles Edward H COO & CFO | Option exercise 10b5-1 | +17,857 | $15.75 | $281K | 253,637 |
| 2025-03-10 | Myles Edward H COO & CFO | Sale 10b5-1 | −112,897 | $35.82 | $4.0M | 140,740 |
| 2025-03-10 | Myles Edward H COO & CFO | Sale 10b5-1 | −29,395 | $34.87 | $1.0M | 111,345 |
| 2025-03-10 | Myles Edward H COO & CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −21,690 | 0 | ||
| 2025-03-10 | Myles Edward H COO & CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −43,122 | 14,378 | ||
| 2025-03-10 | Myles Edward H COO & CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −24,915 | 12,462 | ||
| 2025-03-10 | Myles Edward H COO & CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,313 | 42,500 | ||
| 2025-03-10 | Myles Edward H COO & CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −17,857 | 53,573 | ||
| 2025-02-19 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +16,818 | $4.86 | $82K | 148,104 |
| 2025-02-19 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +2,562 | $7.62 | $20K | 150,666 |
| 2025-02-19 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +11,250 | $10.00 | $113K | 161,916 |
| 2025-02-19 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +17,678 | $15.75 | $278K | 179,594 |
| 2025-02-19 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −39,967 | $37.20 | $1.5M | 139,627 |
| 2025-02-19 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −8,341 | $37.56 | $313K | 131,286 |
| 2025-02-19 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −20,202 | $37.74 | $762K | 111,084 |
| 2025-02-19 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,818 | 5,607 | ||
| 2025-02-19 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,562 | 2,563 | ||
| 2025-02-19 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,250 | 25,313 | ||
| 2025-02-19 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −17,678 | 76,607 |
Page 11 of 12 · 227 trades